Simplex Trading
EWTX icon

Simplex Trading’s Edgewise Therapeutics EWTX Stock Holding History

Simplex Trading’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$545K Buy
17,300
+10,100
+140% +$291K ﹤0.01% 3154
2025
Q4 		$179K Buy
7,200
+4,100
+132% +$82.3K ﹤0.01% 4344
2025
Q3 		$50K Sell
3,100
-13,200
-81% -$187K ﹤0.01% 6458
2025
Q2 		$213K Sell
16,300
-23,600
-59% -$340K ﹤0.01% 4438
2025
Q1 		$877K Sell
39,900
-46,800
-54% -$1.23M ﹤0.01% 2823
2024
Q4 		$2.31M Buy
86,700
+16,800
+24% +$535K ﹤0.01% 2066
2024
Q3 		$1.86M Buy
69,900
+68,800
+6,255% +$1.37M ﹤0.01% 2334
2024
Q2 		$19K Buy
+1,100
New +$19.2K ﹤0.01% 6927
2023
Q3 		– Sell
-4,000
Closed -$31K – 8967
2023
Q2 		$31K Buy
4,000
+100
+3% +$843 ﹤0.01% 6314
2023
Q1 		$26K Buy
+3,900
New +$36.1K ﹤0.01% 6625

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Simplex Trading's EWTX Position: Q1 2026 in Review

Simplex Trading reduced its Edgewise Therapeutics (EWTX) stake by 80% in Q1 2026, selling an estimated $209K and leaving 1,832 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5717.

Simplex Trading first reported a position in EWTX in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.98M in Q3 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Simplex Trading held 1,832 shares of Edgewise Therapeutics worth $57.7K as of Q1 2026.
  • Simplex Trading sold 7,237 Edgewise Therapeutics shares in Q1 2026, an estimated $209K.
  • Edgewise Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5717 holding.
  • Simplex Trading first reported a position in Edgewise Therapeutics in Q1 2023 and has held it in 11 quarters since.
  • Simplex Trading's Edgewise Therapeutics position peaked at $1.98M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.